Biogen (BIIB) Q4 2020 Earnings Report

0 Followers

MX:BIIB Q4 2020 EPS Results

Actual EPS: MXN 85.19
Consensus EPS: ―
Beat/Miss: ―
One Year Ago EPS: MXN 155.12

MX:BIIB Q4 2020 Revenue Results

Actual Revenue: MXN 17.31B
Expected Revenue: ―
Beat/Miss: ―
YoY Revenue Growth: -71.42%

Earnings Announcement Details

Quarter: Q4 2020
Date: 02/03/2021
Time: Before Open
Conference Call: Wednesday, February 3, 2021

MX:BIIB Upcoming Earnings

Biogen's next earnings date is estimated for February 17, 2027, based on past reporting schedules.

Q4 2020 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2020 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2020 Earnings Call Summary

No earnings call summary is available for this earnings event.

MX:BIIB Earnings History

MX:BIIB earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Feb 17, 2027	2026 (Q4)	52.19-	37.01	―	―
Oct 28, 2026	2026 (Q3)	37.0548.73	89.47	-45.53% (-40.73)
Jul 29, 2026	2026 (Q2)	54.6666.96	101.74	-34.19% (-34.78)
Apr 29, 2026	2026 (Q1)	56.8066.40	56.17	18.21% (+10.23)
Feb 06, 2026	2025 (Q4)	30.2237.01	63.98	-42.15% (-26.97)
Oct 30, 2025	2025 (Q3)	72.2089.47	75.89	17.89% (+13.58)
Jul 31, 2025	2025 (Q2)	72.52101.74	98.21	3.60% (+3.53)
May 01, 2025	2025 (Q1)	53.9256.17	68.26	-17.71% (-12.09)
Feb 12, 2025	2024 (Q4)	61.9663.98	54.87	16.61% (+9.11)
Oct 30, 2024	2024 (Q3)	70.1675.89	81.1	-6.42% (-5.21)
Aug 01, 2024	2024 (Q2)	75.6698.21	74.77	31.34% (+23.44)
Apr 24, 2024	2024 (Q1)	64.5468.26	63.24	7.94% (+5.02)
Feb 13, 2024	2023 (Q4)	59.2254.87	75.33	-27.16% (-20.46)
Nov 08, 2023	2023 (Q3)	73.9281.10	88.72	-8.60% (-7.63)
Jul 25, 2023	2023 (Q2)	70.2574.77	97.65	-23.43% (-22.88)
Apr 25, 2023	2023 (Q1)	60.9763.24	67.33	-6.08% (-4.09)
Feb 15, 2023	2022 (Q4)	64.8975.33	63.05	19.47% (+12.28)
Oct 25, 2022	2022 (Q3)	76.7488.72	88.72	0.00% (+0.00)
Jul 20, 2022	2022 (Q2)	75.5297.65	105.65	-7.57% (-8.00)
May 03, 2022	2022 (Q1)	80.7267.33	99.32	-32.21% (-31.99)
Feb 03, 2022	2021 (Q4)	62.8163.05	85.19	-25.98% (-22.13)
Oct 20, 2021	2021 (Q3)	76.0088.72	164.42	-46.04% (-75.70)
Jul 22, 2021	2021 (Q2)	84.61105.65	190.83	-44.64% (-85.19)
Apr 22, 2021	2021 (Q1)	―99.32	170	-41.58% (-70.68)
Feb 03, 2021	2020 (Q4)	―85.19	155.12	-45.08% (-69.94)
Oct 21, 2020	2020 (Q3)	―164.42	170.56	-3.60% (-6.14)
Jul 22, 2020	2020 (Q2)	―190.83	170.19	12.13% (+20.65)
Apr 22, 2020	2020 (Q1)	―170.00	129.83	30.95% (+40.18)
Jan 30, 2020	2019 (Q4)	―155.12	130.01	19.31% (+25.11)
Oct 22, 2019	2019 (Q3)	―170.56	137.64	23.92% (+32.92)
Jul 23, 2019	2019 (Q2)	―170.19	107.88	57.76% (+62.31)
Apr 24, 2019	2019 (Q1)	―129.83	112.53	15.37% (+17.30)
Jan 29, 2019	2018 (Q4)	―130.01	97.83	32.89% (+32.18)
Oct 23, 2018	2018 (Q3)	―137.64	117.36	17.27% (+20.27)
Jul 24, 2018	2018 (Q2)	―107.88	93.74	15.08% (+14.14)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Biogen earnings date